Canaccord Genuity Group Reiterates “Under review” Rating for Totally (LON:TLY)

Totally (LON:TLY)‘s stock had its “under review” rating restated by Canaccord Genuity Group in a research report issued to clients and investors on Thursday, Marketbeat reports.

Totally Stock Performance

LON TLY opened at GBX 1.50 ($0.02) on Thursday. The company has a fifty day moving average of GBX 3.79 and a two-hundred day moving average of GBX 6.45. The company has a debt-to-equity ratio of 14.73, a current ratio of 0.50 and a quick ratio of 0.66. Totally has a 1 year low of GBX 1.27 ($0.02) and a 1 year high of GBX 11.50 ($0.15). The company has a market capitalization of £2.95 million, a PE ratio of -0.78 and a beta of 0.55.

Insider Buying and Selling

In related news, insider John McMullan purchased 1,300,000 shares of the stock in a transaction that occurred on Friday, March 21st. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £52,000 ($68,983.82). Also, insider Simon Stilwell purchased 534,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 26th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,360 ($28,336.43). 13.31% of the stock is currently owned by company insiders.

Totally Company Profile

Totally plc, together with its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland. It operates through Urgent Care, Elective Care, and Corporate Wellbeing segments. The company provides urgent treatment centres which manages front door to A&E departments; NHS 111, GP out of hours services; and clinical assessment services providing telephonic access to multidisciplinary teams of clinicians, and acute visiting services as part of an integrated care system.